Shopping Cart
Remove All
Your shopping cart is currently empty
BW 723C86 is a selective 5-HT2B receptor agonist with anxiolytic activity. It induces overeating and reduced grooming in rats and can be used in neurodegenerative disease research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $52 | - | In Stock |
| Description | BW 723C86 is a selective 5-HT2B receptor agonist with anxiolytic activity. It induces overeating and reduced grooming in rats and can be used in neurodegenerative disease research. |
| In vivo | Subcutaneous administration of 10 and 20 mg/kg BW 723C86 hydrochloride prolonged the duration of feeding behavior in ad libitum-fed rats over a 15-minute period in the observation cage. By systemic administration (subcutaneous injection of 1, 10, and 20 mg/kg, 30 minutes prior to testing), but not intracerebroventricular administration (1-30 μg), BW 723C86 hydrochloride similarly significantly reduced the frequency of grooming behavior in rats in the observation cage. [1] |
| Synonyms | BW723C86 |
| Molecular Weight | 322.85 |
| Formula | C16H19ClN2OS |
| Cas No. | 160521-72-2 |
| Smiles | Cl.O(C=1C=CC=2NC=C(C2C1)CC(N)C)CC=3SC=CC3 |
| Relative Density. | no data available |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (247.79 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (15.49 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.